Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2016
FDA Approval: Uridine Triacetate for the Treatment of Patients Following Fluorouracil or Capecitabine Overdose or Exhibiting Early-Onset Severe Toxicities Following Administration of These DrugsGwynn Ison, Julia A Beaver, W David McGuinn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
U.S. Food and Drug Administration Approval: Cabozantinib for the Treatment of Advanced Renal Cell CarcinomaHarpreet Singh, Michael Brave, Julia A Beaver, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2014
FDA approval summary: vemurafenib for treatment of unresectable or metastatic melanoma with the BRAFV600E mutationGeoffrey Kim, Amy E McKee, Yang-Min Ning, et al.
JAMA Oncology|November 22, 2019
Eligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney CancerSundeep Agrawal, Naomi B Haas, Mohammadhadi Bagheri, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 8, 2026
APOE-associated disease risk and sex-specific effects in Egyptian Alzheimer's disease: an exploratory studyMai Othman, Eman Khedr, Shimaa Heikal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2012
Vandetanib for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease: U.S. Food and Drug Administration drug approval summaryKatherine Thornton, Geoffrey Kim, V Ellen Maher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2021
U.S. FDA Drug Approvals for Gynecological Malignancies: A Decade in ReviewShaily Arora, Preeti Narayan, Gwynn Ison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2022
FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated TumorsJaleh Fallah, Michael H Brave, Chana Weinstock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2020
FDA Approval Summary: Atezolizumab Plus Paclitaxel Protein-bound for the Treatment of Patients with Advanced or Metastatic TNBC Whose Tumors Express PD-L1Preeti Narayan, Sakar Wahby, Jennifer J Gao, et al.
The Journal of Urology|September 11, 2019
Development of Treatments for Localized Prostate Cancer in Patients Eligible for Active Surveillance: U.S. Food and Drug Administration Oncology Center of Excellence Public WorkshopChana Weinstock, Daniel Suzman, Paul Kluetz, et al.
Pageof 6